Shuttle Pharmaceuticals Issues Warrants for 6.7 Million Shares After Milestones

The pre-funded warrants carry a $0.001 exercise price and were issued for no additional cash, as the company had $90 thousand in cash on June 30, 2026.

Stock reaction: SHPH shares closed down 10.5% at $3.49 on Nov. 20, from Nov. 19's close of $3.90. The S&P 500 was down 3.5% that day.

Laboratory equipment. Science laboratory test tubes. Close up. Medical and healthcare concept
Photo: Golden Dayz/Shutterstock.com

Key points

  • Shuttle issued pre-funded warrants for up to 6,693,740 common shares at $0.001 each, with no additional cash received
  • Cash and equivalents were $90 thousand as of June 30, 2026
  • Mining rig threshold for milestone events cut from 2,000 to 500
  • Resale registration statements due Jan. 31, 2027, with milestone shares covered by May 1, 2027

Shuttle Pharmaceuticals (Nasdaq: SHPH) said in an 8-K filed Thursday that it amended its April 30, 2026 securities purchase agreement and issued pre-funded warrants for up to 6,693,740 shares of common stock after determining that three milestone events had been satisfied.

The company's cash and equivalents were $90 thousand as of June 30, 2026. Its net loss for fiscal 2025 was $11.7 million, wider than the $9.1 million loss a year earlier. For the quarter ended June 30, 2026, the net loss was $3.1 million, narrower than $3.7 million a year earlier. The company's record also shows an 8-K filed Aug. 28 with an item titled as a delisting notice and failure to meet a listing standard.

Warrants issued after milestones were met

The warrants were issued under the purchase agreement and a merger agreement with United Dogecoin Inc. The company said it received no additional cash for them. The warrants have an exercise price of $0.001 per share, are exercisable immediately and remain exercisable until exercised in full. Of the 6,693,740 shares, 2,099,142 are tied to purchasers in the securities purchase agreement, 4,097,584 to former stockholders of United Dogecoin, and 497,014 to EF Hutton and one other recipient.

A holder may not exercise a warrant if the holder and its affiliates would then own more than 4.99% of the outstanding common stock, or 9.99% if the holder elects that higher limit. The company said the warrants were issued without registration under Section 4(a)(2) of the Securities Act, and that the purchasers and other recipients represented they are accredited investors.

An Item 8.01 section of the filing gives a separate tally of warrants issued as of Nov. 13: 3,148,713 shares to purchasers, 12,292,751 to former United Dogecoin stockholders and 1,491,042 to EF Hutton and one other recipient, or 16,932,506 shares in total. That total differs from the 6,693,740 figure in the issuance section. The company did not say why the two totals differ.

Milestone threshold cut to 500 rigs

The amendment lowers the number of mining rigs needed for a milestone event from 2,000 to 500. It also sets the second condition as the earlier of Feb. 1, 2027, or the date the company or a subsidiary achieves 90% fleet operational uptime and maintains it for any seven consecutive days, excluding scheduled maintenance and force majeure events. That date must fall within 60 calendar days of when uptime operations began. The company said the amendment does not change the maximum number of milestone shares issuable.

The amendment was entered into Nov. 13, 2026, with investors holding at least 67% of the purchasers under the agreement. The company said the other terms of the purchase agreement remain in effect.

Resale registration deadlines

Under the amendment, the company must file registration statements for resale of the conversion shares and warrant shares by Jan. 31, 2027. One-third of the milestone shares must be covered by March 1, 2027, another third by April 1, 2027, and the last third by May 1, 2027. Each registration statement must be declared effective by the Securities and Exchange Commission by the 10th business day after filing, or by the 90th day if the SEC reviews it, and must not be withdrawn or subject to a stop order.

The amendment is filed as Exhibit 10.1. The 8-K was signed by Chris Cooper, co-chief executive officer.

Sources

Written with AI from the company's SEC filing and our market data, and checked against those sources before publishing. Our editorial standards.

More SEC filing stories

Mergers and acquisitions →
SHPH page →

Filings, figures and price history are on the Shuttle Pharmaceuticals page.